This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S ...

As of January 2026, searches for Men Balance Pro reviews are climbing rapidly as more men recognize a repeating pattern. Low ...

Thousands of men with prostate cancer in England are set to gain access to a life-extending drug within weeks, following a ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

The study retrospectively analyzed 456 biopsy-naive men who underwent PHI testing followed by a prostate biopsy. In this video, Ridwan I. Alam, MD, MPH, an assistant professor of urology at ...

Men often skip prostate, bladder, and kidney screenings. Early detection matters; start based on age and family history to stay healthy. Trump's latest 'unhinged' attack on a female journalist is ...

There's big money in treatments for an enlarged prostate, also known as benign prostatic hyperplasia. Witness the steady ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. During the pandemic, I did what many ...

To examine the role of PHI in detecting clinically significant cancer among biopsy-naïve men with a PSA between 10-20 ng/mL. We studied biopsy-naïve men who underwent PHI testing followed by prostate ...